Bioventix Statistics
Bioventix (51B) Stock Statistics & Valuation Metrics
Total Valuation
Bioventix has a market cap or net worth of EUR 123.37M. The enterprise value is EUR 82.32M.
- Market Cap
- EUR 123.37M
- Enterprise Value
- EUR 82.32M
Share Statistics
Bioventix has 5,224,860 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 5,224,860
- Owned by Insiders
- 6.18%
- Owned by Institutions
- ―
Financial Efficiency
Bioventix’s return on equity (ROE) is 0.67 and return on invested capital (ROIC) is 65.28%.
- Return on Equity (ROE)
- 0.67
- Return on Assets (ROA)
- 0.59
- Return on Invested Capital (ROIC)
- 65.28%
- Return on Capital Employed (ROCE)
- 0.85
- Revenue Per Employee
- 1.08M
- Profits Per Employee
- 634.55K
- Employee Count
- 12
- Asset Turnover
- 1.01
- Inventory Turnover
- 1.65
Valuation Ratios
The current PE Ratio of Bioventix is 13.59. Bioventix’s PEG ratio is -1223736726333776.25.
- PE Ratio
- 13.59
- PS Ratio
- 7.93
- PB Ratio
- 9.02
- Price to FCF
- 12.83
- Price to Operating Cash Flow
- 12.72
- PEG Ratio
- -1223736726333776.25
Income Statement
In the last 12 months, Bioventix had revenue of 12.97M and earned 7.61M in profits. Earnings per share was 1.46.
- Revenue
- 12.97M
- Gross Profit
- 11.81M
- Operating Income
- 9.73M
- Pretax Income
- 9.94M
- Net Income
- 7.61M
- EBITDA
- 9.79M
- Earnings Per Share (EPS)
- 1.46
Cash Flow
In the last 12 months, operating cash flow was 8.09M and capital expenditures -71,600, giving a free cash flow of 8.02M billion.
- Operating Cash Flow
- 8.09M
- Free Cash Flow
- 8.02M
- Free Cash Flow per Share
- 1.54
Dividends & Yields
Bioventix pays an annual dividend of ―, resulting in a dividend yield of 7.84%
- Dividend Per Share
- ―
- Dividend Yield
- 7.84%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 7.79%
- Earnings Yield
- 7.40%
Stock Price Statistics
- Beta
- 0.53
- 52-Week Price Change
- -1.69%
- 50-Day Moving Average
- 19.30
- 200-Day Moving Average
- 17.65
- Relative Strength Index (RSI)
- 63.22
- Average Volume (3m)
- 117
Important Dates
Bioventix upcoming earnings date is Mar 29, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 26, 2026
- Next Earnings Date
- Mar 29, 2027
- Ex-Dividend Date
- ―
Financial Position
Bioventix as a current ratio of 8.53, with Debt / Equity ratio of 0.10%
- Current Ratio
- 8.53
- Quick Ratio
- 8.02
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.54
- Interest Coverage Ratio
- 69524.24
Taxes
In the past 12 months, Bioventix has paid 2.32M in taxes.
- Income Tax
- 2.32M
- Effective Tax Rate
- 0.23
Enterprise Valuation
Bioventix EV to EBITDA ratio is 9.98, with an EV/FCF ratio of 12.17.
- EV to Sales
- 7.53
- EV to EBITDA
- 9.98
- EV to Free Cash Flow
- 12.17
- EV to Operating Cash Flow
- 12.07
Balance Sheet
Bioventix has EUR 5.26M in cash and marketable securities with EUR 10.97K in debt, giving a net cash position of EUR 5.25M billion.
- Cash & Marketable Securities
- EUR 5.26M
- Total Debt
- EUR 10.97K
- Net Cash
- EUR 5.25M
- Net Cash Per Share
- EUR 1.01
- Tangible Book Value Per Share
- EUR 2.18
Margins
Gross margin is 91.01%, with operating margin of 75.04%, and net profit margin of 58.70%.
- Gross Margin
- 91.01%
- Operating Margin
- 75.04%
- Pretax Margin
- 78.84%
- Net Profit Margin
- 58.70%
- EBITDA Margin
- 75.47%
- EBIT Margin
- 75.04%
Analyst Forecast
The average price target for Bioventix is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -4.35%
- EPS Growth Forecast
- -2.97%
Scores
- Smart Score
- 7
- AI Score
- ―
